Sarcoidosis drugs under scrutiny: do they trigger cancer?
NCT ID NCT07343401
First seen Jan 18, 2026 · Last updated May 13, 2026 · Updated 22 times
Summary
This study followed 40 adults with lung sarcoidosis who were taking or about to start immunosuppressive therapy. Researchers checked for new lymphoma cases over 12 months using lymph node biopsies. The goal was to see if these medications increase cancer risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alexandria main university hospital
Alexandria, Asafra, 11511, Egypt
Conditions
Explore the condition pages connected to this study.